Table 3 Comparison of therapeutic effect (n, %)
From: Clinical analysis of 48 cases of malignant superior vena cava syndrome
Group | Clinical effective rate (%) | CR | PR | SD | PD |
|---|---|---|---|---|---|
Group 1 (n = 10) | 50 | 0 | 5 | 5 | 0 |
Group 2 (n = 8) | 62.5 | 0 | 5 | 2 | 1 |
Group 3 (n = 22) | 54.5 | 1 | 11 | 6 | 4 |
Group 4 (n = 8) | 50 | 0 | 4 | 4 | 0 |